Genetic diversity, virulence genotype and antimicrobial resistance of uropathogenic Escherichia coli (UPEC) isolated from sows

Vet Q. 2018 Dec;38(1):79-87. doi: 10.1080/01652176.2018.1519321.

Abstract

Background: Urinary tract infections (UTI) cause severe losses to the swine industry worldwide and uropathogenic Escherichia coli (UPEC) are the main agent isolated from UTI in sows.

Objective: The aim of this study was to investigate the virulence genes, assess the phylogenetic background, clonal diversity, and the pattern of resistance to antimicrobials in 186 isolates of UPEC isolated from sows in Brazil.

Materials and methods: Urine samples from 300 sows of three herds with clinical signs from São Paulo State (Brazil) were screened for UTI; samples with suggestive results were submitted to bacterial isolation. E. coli strains isolated were characterized using disk diffusion technique, polymerase chain reaction and Single-enzyme amplification fragment length polymorphism (SE-AFLP).

Results: Virulence genes focH and papC were present in 78.5% and 58% of strains, respectively, followed by cnf1 (23.2%), afa (13.4%), sfa (11.3%), iucD (6.9%), and hlyA (1.6%). No clonal relatedness was found by SE-AFLP. A total of 98% of isolates (182/186) were multidrug resistant, and the highest levels of resistance were to sulfonamides, tetracycline, florfenicol, and ampicillin. Isolates were classified in phylogenetic group B1 (34.4%), followed by D (33.9%), E (30.1%) and A (1.6%).

Conclusions: The data obtained suggest that pigs from clinically affected herds may serve as a reservoir of uropathogenic and multidrug-resistant E. coli strains.

Keywords: AFLP; Escherichia coli; Swine; phylogenetic group; porcine; resistance; urinary tract infections; virulence genes.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Brazil
  • Drug Resistance, Multiple, Bacterial
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / microbiology
  • Escherichia coli Infections / urine
  • Escherichia coli Infections / veterinary*
  • Female
  • Genetic Variation
  • Genotype
  • Swine
  • Swine Diseases / drug therapy
  • Swine Diseases / microbiology*
  • Swine Diseases / urine
  • Urinary Tract Infections / microbiology
  • Urinary Tract Infections / urine
  • Urinary Tract Infections / veterinary*
  • Uropathogenic Escherichia coli* / drug effects
  • Uropathogenic Escherichia coli* / genetics
  • Uropathogenic Escherichia coli* / isolation & purification
  • Virulence

Substances

  • Anti-Bacterial Agents

Grants and funding

CAPES and CNPq research grants are gratefully acknowledged. M.G.S. (2011/22608-5), M.P.V.C. (14/11523-7), L.Z.M (2013/17136-2; 2016/25745-7), A.P.P. (2017/09515-4) and V.T.M.G. (2013/16946-0) are recipients of fellowships from FAPESP. A.M.M. is a CNPq fellow (grant 309062/2014-4).